Mount Sinai adopts AI platform to advance genomic testing
Mount Sinai Health System, based in New York City, will adopt an artificial intelligence-powered platform from SOPHiA GENETICS to expand its cancer research and genomic testing capabilities. The health system plans to use the SOPHiA DDM Platform to strengthen next-generation sequencing for both blood cancers and solid tumors, supporting care for more than 4,000 oncology […] The post Mount Sinai adopts AI platform to advance genomic testing appeared first on Becker's Hospital Review |...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.